Evidence map›Paper›PMID 32675044›Full record

ReviewPhytomedicine : international journal of phytotherapy and phytopharmacology2021

Contribution of traditional Chinese medicine to the treatment of COVID-19.

Wan-Ying Wang, Ying Xie, Hua Zhou, Liang Liu

Abstract readReview
In one paragraph

Review in Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Investigation of insecticidal activity of twoJournal of plant diseases and protection : scientific journal of the German Phytomedical Society (DPG) · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Traditional Chinese medicine in COVID-19.Acta pharmaceutica Sinica. B · 2021
    Review
  20. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wan-Ying WangFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau.
Ying XieFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau.
Hua ZhouFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau. Electronic address: hzhou@must.edu.mo.
Liang LiuFaculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau. Electronic address: lliu@must.edu.mo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 as an epidemic disease has spread across the planet since December 2019. The somber situation reminds each country to take actions in preventing the spreading of the virus. China as one of the early affected countries has been fighting against the novel coronavirus with the achievements of nearly 80,000 cured confirmed patients. Traditional Chinese medicine (TCM) has made contributions to the treatment of COVID-19 because of its efficacy and comprehensive therapeutic theory. In this commentary, the advantage, etiology and mechanism of TCM therapy were discussed in the aspect of its functions in reducing the harms brought by COVID-19 to human beings.

Indexed as

Medicine, Chinese TraditionalChinaCOVID-19Drugs, Chinese HerbalHumansSARS-CoV-2Drugs, Chinese HerbalCOVID-19Integrated therapyTraditional Chinese medicine

Identifiers

PMID32675044
PMCPMC7338274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.